Cowen And Company, LLC Amicus Therapeutics, Inc. Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$9.89 - $12.7 $128,579 - $165,112	13,001 New	13,001 $158,000
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $328,081 - $518,943	-41,582 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $254,514 - $322,419	-25,918 Reduced 38.4%	41,582 $480,000
Q3 2021 Nov 12, 2021	BUY	$8.74 - $11.84 $406,410 - $550,560	46,500 Added 221.43%	67,500 $645,000
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $95,810 - $117,920	11,000 Added 110.0%	21,000 $202,000
Q1 2021 May 04, 2021	BUY	$9.2 - $23.86 $92,000 - $238,600	10,000 New	10,000 $99,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.